FORM 2
THE PATENTS ACT, 1970
(39 of 1970)
&
THE PATENTS RULES, 2003
COMPLETE SPECIFICATION
(See section 10, rule 13)
“SYSTEM AND METHOD FOR EVALUATING UNDERWRITING
REQUIREMENTS"
SWISS REINSURANCE COMPANY, of Mythenquai 50/60, CH-8022 Zurich, Switzerland.
The following specification particularly describes the invention and the manner in which it is to be performed.


WO 2005/048050 PCT/US2004/036882
2.
SYSTEM AND METHOD FOR EVALUATING UNDERWRITING
REQUIREMENTS
RELATED APPLICATIONS
The present application is related to and claims priority to U.S.
5 Provisional Patent Application Serial No. 60/517,957 entitled "System and Method
for Evaluating Underwriting Requirements" which was filed on November 6,2003 and U.S. Utility Patent Application Serial No. 10/981,852 entitled "System and Method for Evaluating Underwriting Requirements" which was filed on November 5, 2004, the entireties of which are expressly incorporated by reference herein.
10 FIELD OF THE INVENTION
The present invention relates generally to insurance and, more
particularly to systems and methods of evaluating underwriting requirements used in
connection with insurance products, hi certain embodiments, the invention relates to
systems and methods of quantifying the unique and shared value relationships
15 existing between a plurality of underwriting requirements, and evaluating the
impacts) of changing one or more of the requirements.
BACKGROUND AND SUMMARY
Life insurers are increasingly challenged to reduce underwriting expenses and increase underwriting speed and decision making, while maintaining
20 superior mortality protection and promoting fairness in risk selection. Faced with
these mounting pressures, some insurers modify underwriting procedures and practices without folly understanding the potential long term impacts of changes. For some insurers, concerns regarding immediate underwriting costs and simplification of underwriting procedures are paramount. Future mortality costs receive less emphasis
25 since those costs are often difficult to predict with precision, and may be mitigated
through reinsurance arrangements, inflation, and other factors.
SUBSTITUTE SHEET (RULE 26)

WO 2005/048050 PCT/US2004/036882

3
Increased administrative costs resulting from enhanced privacy and security concerns also affect insurers' choices of underwriting requirements. These measures also influence administrative work flow and the manner of dealing with insurance consumers.
5 Insurers can evaluate the impacts of changes in underwriting
procedures and requirements for existing or proposed insurance products by conducting extensive studies and analyses of relevant published data and of their own empirical data. However, such studies are time consuming and laborious. There exists a need for an automated, technologically-based approach to evaluating existing
10 underwriting requirements, and for quickly and cost effectively evaluating the impacts
attendant to changes in such requirements.
15
20
25
One embodiment of the present invention provides a computer method for evaluating expected changes in mortality of an insurable class in response to a
change in underwriting requirements. The method comprise the steps of storing data
relating to protective values of a plurality of underwriting requirements; determining
an expected mortality for the insurable class using a first set of underwriting requirements; changing one or mote of the underwriting requirements of the first set of underwriting requirements; and redetermining the expected mortality for the insurable class using the changed set of underwriting requirements and the stored data
relating to protective values. The embodiment may further comprise the step of
conducting a protective value study to identify the data relating to protective values of the plurality of underwriting requirements. This and other embodiments may also further include the steps of determining prevalence of one or more impairments in a population, and/or identifying one or more impairments uncovered by at least one of
the plurality of underwriting requirements. In the latter case, the method may further
comprise the step of determining one or more causes of death eliminated by screening for impairments uncovered by the underwriting requirements.
30

Certain embodiments may further include die steps of determining to
causes of death eliminated by at least one of the plurality of underwriting
requirements, and comparing the expected causes of death for the insurable class with

WO 2005/048050 PCT/US2004/036882
4
causes of death for the general population. These or other embodiments may further
comprise the step of calculating mortality savings for at least one of the underwriting
requirements. The mortality savings calculated may be stored by age, gender and
smoking status. The step of calculating mortality savings may further comprise the
5 step of calculating unique mortality savings, shared mortality savings and total
mortality savings for the underwriting requirements.
Another embodiment of the invention comprises a computerized
system for evaluating expected changes in mortality of an insurable class in response
to a change in underwriting requirements. The subject system may comprise existing;
10 computer hardware programmed to perform the steps set forth above in connection
with the embodiments of the aforementioned method.
Another embodiment of the invention comprises a computer method of designing a life insurance product This method comprises the steps of storing data relating to protective values of a plurality of underwriting requirements; calculating a
15 unique mortality savings, a shared mortality savings and/or total mortality savings for
at least one of the underwriting requirements; determining an expected mortality for an insurable class using a first set of underwriting requirements; changing one or more of the underwriting requirements of the first step; redetermining the expected mortality for the insurable class using the changed set of requirements; and, using at
20 least one of the determined expected mortality and the redetermined expected
mortality, designing a life insurance product This method may operate iteratively to consider a plurality of sets of underwriting requirements in designing the product The method may be operated so as to achieve a predetermined mortality rate for the insurable class, or to achieve some other targeted objective. The method may further
25 comprise the steps of conducting a protective value study to identify data relating to
protective values of the underwriting requirements, and/or storing either unique, shared or total mortality savings for the underwriting requirements by age, gender and smoking status.
One embodiment of the subject method may further comprise the steps
30 of determining prevalence of one or more impairments in a population, and

WO 2005/048050 PCT/US2004/036882
5

identifying one or more impairments uncovered by at least one of the underwriting
requirements. This or other embodiments may further comprise the steps of
determining one or more causes of death eliminated by screening for one or more
impairments uncovered by the underwriting requirements, and determining total
5 causes of death eliminated by a first set of underwriting requirements and a changed
set of underwriting requirements. Expected causes of death for the insurable class may further be compared with causes of death for a general population.
Yet another embodiment of the subject invention comprises an
automated system for designing a life insurance product. The automated system
10 comprises known computer hardware programmed to accomplish the steps of the
aforementioned methods.
Additional features and advantages of the system and method will
become apparent to those skilled in the art upon consideration of the following
detailed description of an illustrative embodiment which exemplifies the best mode of
15 carrying out the system and method, as presently conceived.
BRIEF DESCRIPTION OF THE DRAWINGS
The present disclosure will be described hereafter with reference to the attached drawings which are given as non-limiting examples only, in which:
Figure 1 is a flow chart illustrating an embodiment of a method and
20 system for evaluating underwriting requirements.
Figure 2 is a continuation of the flow chart of Figure 1.
Figure 3 is a continuation of the flow chart of Figure 2.
Figure 4 is a continuation of the flow chart of Figure 3.
Figure 5 is a graphical representation of shared, unique and total
25 mortality savings as determined from a protective value study for a plurality of
underwriting requirements.

WO 2005/048050 PCT/US2004/036882
6
Figure 6 is a graphical representation illustrating an illustrative example application of the system and method.
Figure 7 is a graphical representation further illustrating an application of the system and method.
5 Figures 8 and 9 are flowcharts illustrating a further embodiment.
The exemplifications set out herein illustrate embodiments of the system and method, and such exemplifications are not intended to be construed as limiting the scope of the invention in any manner.
DETAILED DESCRIPTION OF THE DRAWINGS
10 Figure 1 is a portion of a flow chart 10 which illustrates one
embodiment of a method and system for evaluating underwriting requirements. The flow chart of Figure 1 describes a portion of the embodiment which may be characterized as a "research'' phase. The first step 12 is this embodiment is conducting research relating to the values of a plurality of underwriting requirements.
15 Underwriting requirements are factors considered by an insurer in designing and/or
pricing an insurance product Consideration of underwriting requirements allows an insurer to make judgments regarding the likelihood of occurrence of an insurable event. In the case of life insurance, examples of underwriting requirements include:
1. data collected on an insurance application;
20 2. information collected in a medical examination;
3. blood profiles;
4. urinalysis;
5. electrocardiograms;
6. attending physicians' statements;

25

7. prescription profiles;

WO 2005/048050 PCT/US2004/036882
7
8. motor vehicle reports; and
9. information from a Medical Information Bureau;
An insurer may not use all of the requirement examples listed above in
connection with a particular insurance product. Other requirements may also be used
5 in combination with, or in place of the examples listed. Important considerations in
the selection of requirements used are the costs associated with implementing the
requirement (whether those costs are born by the insurer or the applicant), the speed
with which requirements can be implemented, the useful information provided by the
requirement (i.e., impairments identified by implementing the requirement), whether a
10 requirement is uniquely suited to identify useful information, and other
considerations.
One tool for determining the value of underwriting requirements is known as a protective value study. The step of conducting a protection value study is illustrated in the illustrative embodiment of Figure 1 by step 14. Protective value may
15 be defined as the present value of anticipated excess mortality costs attributable to a
risk uncovered by a particular underwriting requirement A protection value study is a review of existing insurance policies and the underwriting requirements which underlie those policies. The results include a measure of an individual requirement's effectiveness in terms of mortality savings per dollar of policy face amounts. Results
20 may also be expressed as the present value of future death benefits per dollar amount
of insurance-in-force saved by eliminating the anticipated excess mortality cost attributable to the risk uncovered by a requirement Protective value studies that quantify mortality savings require relatively large volumes of data to produce the most desirable results. In general, several thousand cases are needed to draw
25 significant conclusions. However, valuable but less precise information regarding a
requirement's protective value may be obtained through smaller studies.
There are two basic approaches which may be used in conducting a
protective value study. The first approach is a "univariate" method which considers a
single requirement at a time. The alternative is a "multivariate" approach where
30 multiple requirements and their interactions are evaluated simultaneously. Although

WO 2005/048050 PCT/US2004/036882
8
there are advantages and disadvantages to each approach, the multivariate approach is generally preferred in the context of the illustrated embodiments.
There may be certain requirements about which useful information may not be uncovered by a protective value study. The gathering of information
5 regarding such requirements is illustrated in Figure 1 by step 16. In this step, clinical
and epidemiological data are reviewed to determine the prevalence of impairments in the general population. Underwriting requirements which uncover such impairments are identified. Care is taken so as to not "double count" regarding the value of individual requirements, and to correlate the data uncovered in the clinical and
10 epidemiological review with the protective value study results.
In the embodiment of flow chart 10, step 18 represents a determination of impairments uncovered by underwriting requirements. For example, the "blood profile" requirement can be used to uncover lipid abnormalities and/or liver abnormalities. A related step 20 illustrates determining causes of deaths eliminated
15 by screening for a particular impairment with a particular underwriting requirement.
For example, use of a blood profile to screen lipid abnormalities will eliminate a certain percentages of deaths from cardiovascular disease. Similarly, screening for certain liver enzymes will eliminate a certain percentage of deaths from liver disease. In the illustrated embodiment, the results of steps 18 and 20 are combined in step 22
20 in which a determination of total causes of deaths eliminated is given for sets of
underwriting requirements. The sets of underwriting requirements for which such a determination is made can include all possible combinations of requirements considered by the system, or only those particular sets of requirements being evaluated by the method and system which are commonly, or likely to be used by
25 insurers.
Following step 22, the illustrative embodiment verifies the assumptions used in a step illustrated by block 24. The particular manner of verification is discussed in additional detail in connection with Figure 2.
Figure 2 illustrates an additional flow chart portion 26 illustrating an
30 embodiment of a method and system for evaluating underwriting requirements. The

WO 2005/048050

PCT/US2004/036882

9
flow chart of Figure 2 describes a portion of the embodiment which may be characterized as a "validation" or "verification" phase. Step 28 in the flow chart of Figure 2 is a comparison of total mortality savings predicted by the steps discussed in connection with Figure 1 to the protective value results.
5 If the results do not match (step 30), the method and system branches
back to step 20 of Figure 1 for a redetermination of causes of deaths eliminated by screening for a particular impairment. If the results do match, the process proceeds as illustrated in Figure 2. In step 32, insured lives cause of death percentages are collected for a known set of underwriting requirements. This information is not
10 generally publicly available, but may be collected from an insurer's files based on
prior experience, or from comparable sources, m step 34 of Figure 2, information is collected regarding causes of death in the general population. In step 36, adjustments are made to the information collected in step 34 to account for differences between an insured group and the general population. The result is generation of a "pseudo"
15 applicant pool in the preunderwriting stage. In step 38, the known underwriting
requirements that underlie the insured lives cause of death percentages are superimposed on the pseudo insurance applicant pool to create a predicted cause of death distribution for the known requirements. These results are then compared in decision step 40 with the results of step 32. If the results do not match, the process
20 branches back to step 20 of Figure 1 and continues in an iterative manner. If the
results of step 40 do match, the model is used to predict expected mortality savings in instances where mortality experience is known. This operation is illustrated in step 42. In step 44, actual mortality savings achieved in known situations are compared to the expected mortality savings predicted by the model. If the results do not match
25 (step 46), the process again branches back to step 20 of Figure 1 and the process
proceeds iteratively. If the results of the comparison of step 44 match, the process proceeds as illustrated in Figure 3.
Figure 3 is a portion 48 of a flow chart further illustrating an
embodiment of a method and system for evaluating underwriting requirements. The
30 flow chart of Figure 3 illustrates the manner in which the process continues after the
results of the comparisons of step 44 are found to agree, hi certain embodiments, the

WO 2005/048050 PCTAJS2004/03<5882
10

results are compiled in combinations which consider age, gender and smoking status.
This feature is illustrated in the flow chart of Figure 3 by step 50. Step 52 illustrates
the calculation of shared mortality savings for the underwriting requirements.
Similarly, step 54 illustrates the calculation of unique mortality savings for each
5 underwriting requirement. Calculation of both unique and shared mortality savings
help to identify how much duplication occurs between underwriting requirements. Figure 5, discussed below, graphically illustrates example values for particular underwriting requirements.
In step 56, total mortality savings are calculated for a plurality of
10 combinations of individual underwriting requirements. In the illustrated embodiment,
such calculation is made for every possible underwriting requirement under
consideration. Other embodiments may ignore certain combinations which are
unlikely to occur. Following calculation of total mortality savings in step 56, the
results are stored in the operation represented by step 58 for the requirement
15 combinations by age, gender and smoking status.
Following the storage operation of step 58, the process proceeds as illustrated in connection with Figure 4. Figure 4 illustrates a portion 60 of* flow chart of an embodiment of a method and system for evaluating underwriting
requirements. Step 62 of Figure 4 represents a determination or selection of a "base"
20 set of underwriting requirements. This set of underwriting requirements may be an
existing set used by an insurer in connection with a particular product, or a new set to
be evaluated for possible use with a future (or existing) product. In either event, step
64 is an operation in which the mortality savings previously stored in step 58 for the
base underwriting requirement combination are extracted from storage. Using the
25 mortality savings for the particular combination, standard mortality for a block of
business is calculated in step 66. If the evaluation of alternative scenarios (i.e.,
alternative underwriting requirement combinations) is not required or desired, the
base line mortality rates calculated in step 66 are outputted (step 68) and stored (step
70). If the evaluation of alternative scenarios is desired, the process continues as
30 illustrated in Figure 4. Specifically, changes exemplified by steps 72,74 and 76 may
be made. These include changing the limits used in connection with underwriting

WO 2005/048050 PCT/US2004/036882
11

requirements in the combination (step 72), adding a new underwriting requirement to the combination (step 74), or removing one of the underwriting requirements from the combination (step 76). These steps may be practiced singly or in combination. After the desired change is made, mortality savings for the "new" set of underwriting
5 requirements are extracted, as illustrated by step 78. Expected changes in mortality
are then calculated, as indicated in step 80. If the results of the calculation are not acceptable (or if other alternatives are to be generated for comparison), the process returns as illustrated to steps 72,74 and/or 76. The process may proceed iteratively until the result of the calculation of step 80 is acceptable. These results are outputted
10 (step 82) and stored (step 70), as indicated in Figure 4.
The results produced and stored in step 70 may be used as indicated in step 84 to evaluate or determine pricing in connection with new or existing insurance products, or for the design and development of a new insurance product
Figure 5 is a graphical representation of shared, unique and total
1 5 mortality savings as determined from a protective value study for a plurality of
underwriting requirements. As previously noted, the "unique value" represents the
present value of mortality savings solely attributable to a particular underwriting
requirement The "shared" value represents the present value of mortality savings
mat considers the influence of all other requirements that contributed information
20 toward the classification of me risk. Consideration of both shared and unique values
identifies duplication which occurs between multiple requirements, and which
requirements may represent "core" requirements having the greatest impact on
mortality. The unique and shared values also demonstrate value associated with
confirming and refining knowledge gained through multiple underwriting requirement
25 sources.
One simplified example of an application of the illustrated method will
now be described. Company XYZ is a provider of term life insurance. For
simplicity, it will be assumed that the product offered by Company XYZ has only one
non-tobacco preferred class and a residual standard class. Minimum policy size is
30 $ 100,000 and all applicants are paramedically examined with complete blood and

WO 2005/048050 PCT/US2004/036882
12
urine testing. Preferred criteria allow blood pressure up to 140/85, total cholesterol up
to 205, cholesterol/hdl ratio of 5.0, and a BMI of 29.2. Company XYZ would like to
know the incremental and total impact on expected mortality if blood tests are
dropped, and if medical history questionnaires instead of full paramedical exams are
5 used at certain ages. Age and amount guidelines for the current and proposed
products are the same, and only one age and amount band is considered here for illustrative purposes.
Figure 6 illustrates the current baseline mortality for me preferred class (line 90 of Figure 6). Line 92 of Figure 6 illustrates expected mortality if blood tests
10 are dropped. As indicated, mortality would increase 30% in durations 1-5, and 26%
in durations 6-10. In this hypothetical example, 23% of applicants would be expected to qualify for the preferred non-tobacco class under current guidelines. If Company XYZ changes its definition of preferred by relying on urine tests rather man both blood and urine tests, and relies upon self reported cholesterol values, those qualifying
15 for the preferred product would increase significantly to 53%, and more residual class
risks would qualify for the preferred class. Accordingly, expected preferred mortality from the original baseline to the new baseline would be expected to increase by an avenge of 20% for this age and amount grouping.
Figure 7 further illustrates the cumulative effect on expected preferred
20 mortality if a medical history questionnaire is used instead of a full paramedical exam,
and if urine tests are substituted for blood and urine tests. The expected mortality in
this case is illustrated by line 94. The cumulative effect is a mortality increase of 66%
in durations 1-5 and 58% in durations 6-10. In addition to the changes generated by
eliminating blood tests, switching to a non-medical questionnaire without benefit of a
25 physical examination contributes additional increases in preferred mortality due to the
inability to verify build (BMI) and blood pressure.
Reasons why Company XYZ might want to evaluate such changes
include the costs associated with the subject requirements. For example, urine tests
may be substantially easier and less expensive to obtain, when compared to blood
30 tests. Similarly, use of a medical history questionnaire is likely to be easier and less

WO 2005/048050 PCT/US2004/036882
13
expensive than a full paramedical examination. Evaluation of the expected impacts of such changes on mortality of the insured group will allow insurers such as Company XYZ to make economically rational decisions regarding such changes.
A further example will illustrate the manner in which causes of death
5 and unique and shared mortality savings are determined. For simplicity, assume that
an insurance product has only two underwriting requirements: blood tests and motor vehicle reports (MVR). Blood tests uncover (among other impairments) lipid abnormalities and liver abnormalities. MVR uncovers motor vehicle violations, including speeding tickets, DUIs (driving under the influence of alcohol), and others.
10 For illustrative purposes, we will consider two opposite causes of death: ischemic
heart disease (IHD) and motor vehicle accidents (MVA). Assume the following causes of death are eliminated by screening for the above impairments: screening for lipid abnormalities eliminates 50% of IHD deaths and 0% of MVA deaths; screening for liver abnormalities eliminates 0% of IHD deaths and 20% of MVA deaths (liver
15 abnormalities indicate excessive drinking and drunk driving is attributable to a large
proportion of motor vehicle deaths); screening for motor vehicle violations eliminates 0% of IHD deaths and 50% of MVA deaths. Finally, assume Oat 90% of the 20%, or 18% (0.9*20%X of the MVA deaths eliminated by elevated Kver values would be uncovered by the MVR (ex: applicant had a DUI). Now assume the following cause
20 of death distributions for different ages before underwriting:

DEATHS PER 1,000,000 BEFORE UW REQ.
COD M25 M45 M65 M85
Ischemic HD 10 100 500 7,000
Motor Vehicle Accidents 150 100 200 500
TOTAL COD 160 200 700 7,500

WO 2005/048050 PCT/US2004/036882
14
If only blood tests are required, the total mortality savings would be
50% of IHD deaths (from lipids) and 20% of MVA deaths (from liver). If only MVR
is required, the total mortality savings would be 0% of IHD deaths and 50% of MVA
deaths. If both blood tests and MVR are required, the total mortality savings would
5 be 50% of IHD deaths and 52% (50% + 20% - 18%) of MVA deaths. This leads to
the following grid:

Absolute Deaths Eliminated by UW Test % Decrease in Mortality
UWTest M25 M45 M65 M85 M25 M45 M65 M85
No Test 0 0 0 0 0% 0% 0% 0%
Blood Profile 35 70 290 3600 -22% -35% -41% -48%
MVR 75 50 100 250 -47% -25% -14% -3%
Both 83 102 354 3760 -52% -51% -51% -50%
Reading the chart for a male age 45: 70 deaths are eliminated by
collecting blood alone (70 = 50% * 100 + 20% * 100); 50 deaths are eliminated by
10 collecting MVR alone (50 = 0 * 100 + 50% * 100); and if both requirements are
collected, the unique value for blood is 52 (50 from IHD, 2 from MVA), the unique value for the MVR is only 32 (50 - 18 deaths uncovered by both requirements), and the shared value is 18.
Consideration of both unique and shared values are important because,
15 if blood tests are dropped for males age 45, a mortality savings of 70 will NOT be
lost Rather, a mortality savings of only 52 will be lost, since the shared mortality savings of 18 is uncovered by either blood tests or MVR.
It is further noted that, basing the model on the underlying causes of
death naturally adjusts for the importance of different underwriting requirements by
20 age. For example, at age 25, most of the mortality savings (in this simplified

WO 2005/048050

15

PCT/US2004/036882

example) can be achieved simply by obtaining an MVR. However, at age 85, collecting blood is far more important than the MVR.
Figures 8 and 9 illustrate a further embodiment, as referenced in claims 39 through 50.
5 Although the system and method have been described with reference to particular embodiments, from the foregoing description, one skilled in the art can easily ascertain the essential characteristics of the system and method, and various changes and modifications may be made to adapt the various uses and characteristics without departing from the spirit and scope of the invention as set forth in the claims.

WO 2005/048050 PCT/US2004/036882
16
WHAT IS CLAIMED IS:
1. A computer method for evaluating expected changes in mortality of an insurable class in response to a change in underwriting requirements,
5 comprising the steps of:
a. storing data relating to protective values of a plurality of
underwriting requirements;
b. determining an expected mortality for the insurable class using
a first set of underwriting requirements;
10 c. changing one or more of said first set of underwriting
requirements; and
d. redetermining the expected mortality for the insurable class using the changed set of underwriting requirements and the stored data relating to protective values.
15 2. The method of Claim 1, wherein the step of storing data
relating to protective values of a plurality of underwriting requirements comprises the step of storing at-feast one of a unique protective value, a shared protective value and a total protective value for at least one of said underwriting requirements.
3. The method of Claim 1, wherein the step of determining the
20 expected mortality comprises the step of calculating mortality savings for at least one
of the plurality of underwriting requirements.
4. The method of Claim 3, further comprising the step of storing
mortality savings for said at least one of the plurality of underwriting requirements by
age, gender and smoking status.
25 5. The method of Claim 3, wherein the step of calculating
mortality savings comprises the step of calculating at least one of unique mortality savings, shared mortality savings and total mortality savings for said at least one of the plurality of underwriting requirements.

WO 2005/048050

17

PCT/US2004/036882

6. The method of Claim 1, further comprising the step of storing data relating to prevalence of one or more impairments in a population.
7. The method of Claim 1, further comprising the step of identifying one or more impairments uncovered by at least one of the plurality of
5 underwriting requirements.
8. The method of Claim 7, further comprising the step of
determining one or more causes of death eliminated by screening for said one or more
impairments uncovered by at least one of the plurality of underwriting requirements.
9. The method of Claim 1, further comprising the step of
10 determining total causes of death eliminated by at least one of said first set of
underwriting requirements and said changed set of underwriting requirements.
10. Thememc4ofClauii9,fiii1herconn)rising1hestepof
comparing expected causes of death for the insurable class with causes of death for a
general population.
15 11. A computerized system for evaluating expected changes in
mortality of an insurable class in response to a change in underwriting requirements,
comprising:
a. means for storing data relating to protective values of a
plurality of underwriting requirements;
20 b. means for determining an expected mortality for the insurable
class using a first set of underwriting requirements;
c. means for changing one or more of said first set of
underwriting requirements; and
d. means for redetermining the expected mortality for the
25 insurable class using me changed set of underwriting requirements and the stored data relating to protective values.
12. The system of Claim 11, wherein said means for storing data comprises means for storing at least one of a unique protective value, a shared

WO 2005/048050 PCT/US2004/03